PRO-DEX, INC. Increase (Decrease) in Customer Advances
PRO-DEX, INC. (PDEX) reported Increase (Decrease) in Customer Advances of $103.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-30.
Financial Statements › Notes
us-gaap:IncreaseDecreaseInCustomerAdvances · last filed 2026-04-30
- PRO-DEX, INC. increase (decrease) in customer advances for the quarter ending 2026-03-31 was $103.00K.
- PRO-DEX, INC. increase (decrease) in customer advances for the quarter ending 2025-12-31 was $41.00K.
- PRO-DEX, INC. increase (decrease) in customer advances for the quarter ending 2024-03-31 was $225.00K.
| Period end | Increase (Decrease) in Customer Advances 3 month | Increase (Decrease) in Customer Advances 6 month | Increase (Decrease) in Customer Advances 9 month |
|---|---|---|---|
| 2026-03-31 | $103.00K 10-Q · filed 2026-04-30 | $144.00K derived: sum of 2 quarters · filed 2026-04-30 | $144.00K 10-Q · filed 2026-04-30 |
| 2025-12-31 | $41.00K 10-Q · filed 2026-01-29 | $41.00K 10-Q · filed 2026-01-29 | |
| 2024-03-31 | $225.00K 10-Q · filed 2025-05-01 | $267.00K 10-Q · filed 2025-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |